ADA Scientific Sessions 2026 Abstract · Jun 5, 2026
Age at Menopause Modifies the Effect of Clinical Risk Factors on Coronary Artery Disease (CAD) Incidence in Women with Type 1 Diabetes (T1D)
By ROMANO S, COSTACOU T, EL KHOUDARY S et al.
Introduction and Objective: Women with T1D have greater CAD risk and earlier age at final menstrual period (FMP). While no direct association between age at FMP and CAD has been observed in T1D, we evaluated if age at FMP modifies associations between clinical risk factors and 32-year CAD incidence. Methods: We analyzed n=121 postmenopausal women from the Epidemiology of Diabetes Complications T1D cohort (baseline mean age 28, baseline T1D duration 19 yrs, median age at FMP=50). Risk factors included HbA1c, estimated glucose disposal rate, lipids, blood pressure, makers of kidney damage/function, and BMI. Cox models for CAD tested for statistical interaction between age at FMP and baseline and time-varying risk factors (up to 9 measures over 30 yrs). Results: N=54 (44%) developed CAD over 32 yrs. Although age at FMP was not associated with CAD (HR=0.95, 95% CI 0.89, 1.01), it modified the association between baseline HDL-C (p=0.08), albumin excretion rate (p=0.09), and estimated glucose disposal rate (p=0.02) and CAD; associations with CAD were stronger in women with later FMP (Table 1). There were no interactions observed in time-varying analyses. Conclusion: Weaker associations between clinical risk factors and CAD in women with earlier FMP suggests early menopause may reflect advanced biological aging that outweighs the contribution of individual factors. Further research should explore mechanisms of CAD risk by FMP timing. Disclosure: S. Romano: None. T. Costacou: None. S. El Khoudary: Consultant; Current; Novo Nordisk. T. Orchard: None. M. Feghali: None. R.G. Miller: None. Funding: American Diabetes Association (7-23-ICTSWH-19), NIDDK (R01DK034818)